Advaxis, Inc. (ADXS)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Ken Berlin
Employees:
20
9 DEER PARK DRIVE, SUITE K-1, MONMOUTH JUNCTION, NJ, 08852
732 545 1590
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
-
Formally known as:
- ADVAXIS INC (NEW) COM STK (DE)
- ADVAXIS INC (NEW) COM STK (DE)
- Advaxis Inc.
- Advaxis Inc.
Date | Ratio |
---|---|
2013-07-15 | 1:125 |
2019-03-29 | 1:15 |
Advaxis, Inc. focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|